If you are a Healthcare Professional and you would like to log in to access this content, please click "Login".
You are now leaving the Lilly Medical Web site
Please use a minimum of three unique search wordsOur search is configured to only display links relevant to answer your question. For the best results please use specific and relevant keywords that accurately reflect the information you are seeking.Please do not use this field to report adverse events or product complaints. Adverse events and product complaints should be reported. Reporting forms and information can be found at UK: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events and product complaints should also be reported to Lilly: please call Lilly UK on 01256 315 000.
This information is intended for UK registered healthcare professionals only as a scientific exchange in response to your search for information. Please refer to the link for full prescribing information:
Emgality Summary of Product Characteristics (SmPC)
The pre-filled pen has visual and audible signals to confirm the injection was successfully completed.
to tell if an Injection is complete
Instructions for Use state the following:
you press the teal injection button, you will hear 2 loud clicks.
and hold the teal injection button; you will hear a loud click
will hear a second click in about 5 to 10 seconds after the first
second click tells you that the injection is complete. 1
will know the injection is complete when you can see the grey plunger
at the top of the clear base. 1
if more than 2 Clicks are heard during the Injection - 2 loud Clicks
and a soft One. Is the Injection complete?
patients may hear a soft click right before the second loud click.
That is normal operation of the pen. The pen should not be removed
from the skin until the second loud click is heard.1
with vision or hearing problems should not use the pen without help
from a caregiver.1
instructions for using the pen included with the Package Leaflet,
must be followed carefully. The pre-filled pen is for total use
training, patients may self-inject galcanezumab if a healthcare
professional determines that it is appropriate. 2
Emgality [instructions for use]. Eli Lilly Nederland B.V., The
Emgality [summary of product characteristics]. Eli Lilly Nederland
B.V., The Netherlands.
medicinal product is subject to additional monitoring. This will
allow quick identification of new safety information. Healthcare
professionals are asked to report any suspected adverse reactions.
Date of Last Review:March 18, 2019
Was this answer helpful to you?
Call or Email us
If you want to ask a Medical Information question or you want to report an adverse event or product complaint you can call us or email us at firstname.lastname@example.org